Photo from wikipedia
Doravirine is a non‐nucleoside reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus (HIV)‐1 infection. This phase 1 study in healthy adults investigated the pharmacokinetics, safety and tolerability… Click to show full abstract
Doravirine is a non‐nucleoside reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus (HIV)‐1 infection. This phase 1 study in healthy adults investigated the pharmacokinetics, safety and tolerability of long‐acting parenteral (LAP) microsuspension formulations of doravirine administered as an intramuscular (IM) injection.
Keywords:
long acting;
safety tolerability;
acting parenteral;
pharmacokinetics safety;
tolerability long;
formulations doravirine
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!